Literature DB >> 17113670

Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs).

Barbara Alicja Jereczek-Fossa1, Federica Cattani, Alberto D'Onofrio, Raffaella Cambria, Anna Kowalczyk, Anna Corallo, Andrea Vavassori, Dario Zerini, Giovanni Battista Ivaldi, Ottavio DeCobelli, Roberto Orecchia.   

Abstract

PURPOSE: To compare dose distribution for two techniques of 3-dimensional conformal radiotherapy (RT): 6-field technique (6F) and 2-dynamic arc therapy (2DA). METHODS AND MATERIALS: Thirty nonmetastatic prostate cancer patients were included. In each patient, two treatment plans were prepared: with six coplanar fields (45 degrees , 90 degrees , 135 degrees , 225 degrees , 270 degrees , 315 degrees ) and with two dynamic lateral 100 degrees -wide arcs (40-140 degrees , 220-320 degrees ). Dose-volume histograms (DVHs) were computed and mean area under curve (AUC) values were calculated for the DVHs of Planning Target Volume (PTV), rectum, urinary bladder and femoral heads. Doses given to 30% of rectum (DR(30)), to 60% of rectum (DR(60)), to 50% of bladder (DB(50)), to 50% of femoral head (DF(50)) and to 95% of PTV (DPTV(95)) were reported as a percentage of the total dose.
RESULTS: Mean DR(30) and DR(60) for 6F and 2DA were 75.8%, 51.5% and 72.2%, 37.2%, respectively. Mean DB(50) for 6F and 2DA were 68% and 64.2%, respectively. Mean right DF(50) for 6F and 2DA were 35.4% and 45.5%, respectively. Mean DPTV(95) for 6F and 2DA were 99% and 99.2%, respectively. Mean AUCs of DVHs of rectum and urinary bladder were significantly higher for 6F (this was more evident for small PTV and in the intermediate dose range). Mean AUC of DVHs of PTV and femoral heads were significantly higher for 2DA.
CONCLUSIONS: Both 6F and 2DA offer good dose distribution for PTV. 2DA allows for significantly better sparing of rectum and urinary bladder with slightly worse femoral head dose distribution. Further study is warranted in order to establish the clinical relevance of these differences.

Entities:  

Mesh:

Year:  2006        PMID: 17113670     DOI: 10.1016/j.radonc.2006.10.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer.

Authors:  R Cambria; F Cattani; B A Jereczek-Fossa; F Pansini; D Ciardo; S Vigorito; S Russo; D Zerini; L Cozzi; R Orecchia
Journal:  Strahlenther Onkol       Date:  2014-02-21       Impact factor: 3.621

2.  Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  B A Jereczek-Fossa; A Maucieri; G Marvaso; S Gandini; C Fodor; D Zerini; G Riva; O Alessandro; A Surgo; S Volpe; G Fanetti; S Arculeo; M A Zerella; S Parisi; P Maisonneuve; A Vavassori; F Cattani; R Cambria; C Garibaldi; A Starzyńska; G Musi; O De Cobelli; M Ferro; F Nolè; D Ciardo; R Orecchia
Journal:  Med Oncol       Date:  2018-11-27       Impact factor: 3.064

3.  Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.

Authors:  Masahide Saito; Toshihiro Suzuki; Yuya Sugama; Kan Marino; Naoki Sano; Takafumi Komiyama; Shinichi Aoki; Yoshiyasu Maehata; Kazuya Yoshizawa; Kazunari Ashizawa; Hidekazu Suzuki; Koji Ueda; Yosuke Miyasaka; Masayuki Araya; Hiroshi Takahashi; Hiroshi Onishi
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

4.  Evaluation of the dynamic conformal arc therapy in comparison to intensity-modulated radiation therapy in prostate, brain, head-and-neck and spine tumors.

Authors:  Manuel A Morales-Paliza; Charles W Coffey; George X Ding
Journal:  J Appl Clin Med Phys       Date:  2010-12-19       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.